✦ LIBER ✦

48 Phase I study of HSPPC-96 (oncophage®) vaccine in patients with completely resected pancreatic adenocarcinoma

✍ Scribed by R.G. Maki; J.J. Lewis; S. Janetzki; D. Klimstra; D. DeSantis; C. Hirst; A.N. Houghton; P.K. Srivastava; M.F. Brennan

Book ID: 118620224
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 163 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90082-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized pilot phase I study of modi

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma

✍ Daniel M Geynisman, Yuanyuan Zha… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 622 KB

Ex vivo ras peptide vaccination in patie

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study

✍ Marianne K. Gjertsen; Arne Bakka; Jarle Breivik; Ingvil Saeterdal; Tobias Gedde- 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 434 KB 👁 2 views

In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding

A phase I study of IMP321 and gemcitabin

A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma

✍ Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 174 KB

Phase I study of a MUC1 vaccine composed

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

✍ Ramesh K. Ramanathan; Kenneth M. Lee; John McKolanis; Elizabeth Hitbold; Wolfgan 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 478 KB

A phase I/II study of leucovorin, carbop

A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas

✍ Rigg, A; Cunningham, D; Gore, M; Hill, M; O'Brien, M; Nicolson, M; Chang, J; Wat 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 834 KB

624 poster A phase I radiation dose-esca

624 poster A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly Gemcitabine in patients with locally advanced pancreatic adenocarcinoma

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB